CD4 and tuberculosis: Recent research findings suggest additional benefits of ART, including the HPTN 052 trial results that demonstrated almost complete interruption of HIV transmission for patients on ART [8], and a meta-analysis revealing how the effect of ART on TB risk is modified by CD4 cell count [9].